Insider Buying: The Altimmune, Inc. (NASDAQ:ALT) Independent Director Just Bought 6.6% More Shares
yahoo.com
news
2022-05-31 10:08:06

Even if it's not a huge purchase, we think it was good to see that David Drutz, the Independent Director of Altimmune, Inc. (NASDAQ:ALT) recently shelled out US$5.4k to buy stock, at US$4.50 per share. Although the purchase is not a big one, increasing their shareholding by only 6.6%, it can be interpreted as a good sign.

See our latest analysis for Altimmune

The Last 12 Months Of Insider Transactions At Altimmune

Notably, that recent purchase by David Drutz is the biggest insider purchase of Altimmune shares that we've seen in the last year.
